Back to search
Blepharospasm, Benign Essential
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Blepharospasm, Benign Essential trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Blepharospasm, Benign Essential trials you may qualify forThis study aims to provide real-world information about the duration, safety, and overall benefit of DaxibotulinumtoxinA (also called DAXI) treatment for adults…
Benign essential blepharospasm (BEB) is a functionally disabling focal dystonia. Botulinum neurotoxin (BoNT) therapy is suboptimal in many BEB patients. Repetit…
This pilot study aims at investigating the role of superior colliculus in patients with idiopathic blepharospasm (BSP) de novo, compared to healthy subjects.